This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Universitat Heidelberg. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Anca Remes: Innovator in NFAT Binding Polynucleotides
Introduction
Anca Remes is a notable inventor based in Kiel, Germany. She has made significant contributions to the field of molecular biology, particularly in the development of polynucleotides that target the Nuclear factor of activated T-cells (NFAT). Her work has implications for treating and preventing various diseases.
Latest Patents
Anca Remes holds a patent for her invention titled "NFAT binding polynucleotides." This patent describes a polynucleotide that includes a NFAT binding site sequence and its reverse complement, separated by a spacer sequence. The invention is aimed at treating and preventing diseases associated with NFAT, as well as related viral particles and compositions.
Career Highlights
Anca is affiliated with the prestigious University of Heidelberg, where she conducts her research. Her innovative work has led to advancements in understanding NFAT-mediated diseases, showcasing her expertise in the field.
Collaborations
Anca has collaborated with esteemed colleagues, including Oliver Müller and Hugo Katus. These partnerships have further enriched her research and contributed to the scientific community.
Conclusion
Anca Remes is a pioneering inventor whose work on NFAT binding polynucleotides holds promise for medical advancements. Her contributions to the field continue to inspire future research and innovation.
